Chronic kidney disease (CKD) represents a growing public health problem associated with
loss of kidney function and cardiovascular disease (CVD), the main leading cause of …

Chronic kidney disease (CKD) is a public health concern that affects approximately 10% of
the global population. CKD is associated with poor outcomes due to high frequencies of …

The relationship of gut microbiota and calcium oxalate stone has been limited investigated,
especially with no study of gut microbiota and short chain fatty acids (SCFAs) in …

Background The gut microbiome is altered in chronic kidney disease (CKD), potentially
contributing to CKD progression and co-morbidities, but population-based studies of the gut …

Short-chain fatty acids (SCFAs) are metabolites produced in the gut via microbial
fermentation of dietary fibers referred to as microbiota-accessible carbohydrates (MACs) …

Renal cell carcinoma (RCC) accounts for about 2% of cancer diagnoses and deaths
worldwide. Recent studies emphasized the critical involvement of microbial populations in …

The gut microbiome is known to play an important role in the day-to-day physiology and
health of the human host. It is, therefore, not surprising that there is interest surrounding the …

Seminal works have now revealed the gut microbiota is connected with several diseases,
including renal disorders. The balance between optimal and dysregulated host-microbiota …

Renal impairment associated with chronic kidney disease (CKD) causes the buildup of
uremic toxins that are deleterious to patient health. Current therapies that manage toxin …

The workings of the gut microbiome have gained increasing interest in recent years through
the mounting evidence that the microbiota plays an influential role in human health and …